Tag: Recist

According to the National Cancer Institute, stable disease refers to cancer that is neither significantly decreasing nor increasing in extent or severity. This medical term is a common outcome in oncology and helps doctors evaluate a patient's response to treatment, defining what does it mean stable disease for their specific condition.

In oncology, while a complete response (CR) or partial response (PR) is often the goal, a significant number of patients on therapy will experience stable disease (SD). Understanding **what is the duration of stable disease** is a critical, yet complex, component of assessing treatment effectiveness and managing expectations for cancer patients.

According to the National Cancer Institute, a partial response is a decrease in the size of a tumor or in the extent of cancer in the body, but not a complete disappearance of the disease. Understanding **what does partial response mean?** is a crucial step for patients, as it often indicates a positive, though incomplete, reaction to a given therapy.

In clinical oncology, physicians use standardized criteria like RECIST to classify a disease's response to treatment. Knowing **what is the difference between stable disease and progressive disease** is crucial for understanding how a particular therapy is impacting a condition, particularly in cancer.